Comportamiento de los alelos HLA-DQB1*02 y HLA-DQB1*03 en pacientes con diagnóstico presuntivo de enfermedad celíaca

Torres Odio, Sylvia; Martínez Córdova, Zuzet; Calzadilla Lugo, Flora; García González, Igrid; Santana Porbén, Sergio; Noa Pedroso, Guillermo; Hernández Casas, Yoandy; Gutiérrez Rojas, Ángela Rosa; Domínguez Álvarez, Carlos.
Rev. cuba. med ; 50(3)jul.-sept. 2011. tab, graf
Artículo en Español | CUMED | ID: cum-57092

Documentos relacionados

  1. Medium-high resolution electrochemical genotyping of HLA-DQ2/DQ8 for detection of predisposition to coeliac disease.
  2. A multiplex assay to rapidly exclude HLA-DQ2.5 and HLA-DQ8 expression in patients at risk for celiac disease.
  3. [Clinical analysis of gluten-related disease].
  4. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles.
  5. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.
  6. Human leukocyte antigen matching in organ transplantation: what we know and how can we make it better (Revisiting the past, improving the future).
  7. The influence of HLA-DQ2 heterodimers on the clinical features and laboratory of patients with celiac disease
  8. Is celiac disease better identified through HLA-DQ8 than through HLA-DQ2 in Mexican subjects?
  9. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020.
  10. Ex-vivo whole blood secretion of interferon (IFN)-γ and IFN-γ-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-γ enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2·5(+) -associated coeliac disease.